IC
TAK icon

Inscription Capital’s Takeda Pharmaceutical TAK Stock Holding History

Inscription Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$408K Buy
22,011
+778
+4% +$13.7K 0.04% 414
2025
Q4 		$331K Buy
21,233
+17
+0.1% +$243 0.03% 459
2025
Q3 		$311K Buy
21,216
+2,557
+14% +$38K 0.03% 479
2025
Q2 		$288K Sell
18,659
-3,160
-14% -$46.7K 0.04% 371
2025
Q1 		$303K Buy
+21,819
New +$306K 0.05% 246
2024
Q3 		$322K Buy
22,663
+94
+0.4% +$1.33K 0.05% 257
2024
Q2 		$292K Buy
22,569
+750
+3% +$9.93K 0.05% 251
2024
Q1 		$303K Buy
+21,819
New +$317K 0.05% 246
2019
Q2 		– Sell
-14,920
Closed -$304K – 217
2019
Q1 		$304K Buy
+14,920
New +$300K 0.16% 88

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return